Stereotactic body radiation therapy versus radiofrequency ablation for single small hepatocellular carcinoma: a propensity-score matching analysis of their impact on liver function and clinical outcomes.

Ueno, Masayuki; Takabatake, Hiroyuki; Itasaka, Satoshi; Kayahara, Takahisa; Morimoto, Youichi; Yamamoto, Hiroshi; Mizuno, Motowo

Ueno, Masayuki; Takabatake, Hiroyuki; Itasaka, Satoshi; Kayahara, Takahisa; Morimoto, Youichi; Yamamoto, Hiroshi; Mizuno, Motowo.

Afiliación

Ueno M; Department of Gastroenterology and Hepatology, Kurashiki Central Hospital, Okayama, Japan.
Takabatake H; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Itasaka S; Department of Gastroenterology and Hepatology, Kurashiki Central Hospital, Okayama, Japan.
Kayahara T; Department of Radiation Oncology, Kurashiki Central Hospital, Okayama, Japan.
Morimoto Y; Department of Gastroenterology and Hepatology, Kurashiki Central Hospital, Okayama, Japan.
Yamamoto H; Department of Gastroenterology and Hepatology, Kurashiki Central Hospital, Okayama, Japan.
Mizuno M; Department of Gastroenterology and Hepatology, Kurashiki Central Hospital, Okayama, Japan.

J Gastrointest Oncol ; 12(5): 2334-2344, 2021 Oct.

Article en En | MEDLINE | ID: mdl-34790396

Palabras clave

Hepatocellular carcinoma (HCC); liver function; propensity-scores; radiofrequency ablation (RFA); stereotactic body radiation therapy (SBRT)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Gastrointest Oncol Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google